The latest glucagon-like peptide 1 (GLP-1) receptor agonists have been heralded for their potential to not only boost weight loss and glucose ... tirzepatide, and new GLP-1 drugs in the ...
Compounded by the equally sudden banning of the weight loss drug, phen-fen (phentermine-fenfluramine ... there remained no new promising pharmaceutical agents addressing obesity.
Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...